USA: A new study published in the Journal of Diabetes and Its Complications suggests that tirzepatide, a novel dual ...

There’s a zap for that. Scientists have unsheathed an electriying new treatment for erectile dysfunction that’s reportedly better than popping a little blue pill — radio waves. New research ...

Erectile dysfunction medication could reduce the risk of Alzheimer’s disease, a new study is suggesting, though some experts cast doubt on the link between the two.

A new study conducted on medical students found that those who suffer from Irritable Bowel Syndrome are 108 percent more likely to develop erectile dysfunction.

Read the full paper here. The post Study finds erectile dysfunction for 1 in 5 men even years after Covid infection appeared first on Boing Boing.

The study followed over 269,000 participants for five years, and those who were prescribed erectile dysfunction drugs were 18% less likely to develop Alzheimer’s than those who weren’t.

Tirzepatide and injectable semaglutide were associated with the greatest weight loss after a year of treatment among several GLP-1 receptor agonists, a recent study showed.“Despite being the ...

New research highlights that 65.8% of diabetic men suffer from erectile dysfunction. Early detection and better diabetes control are key to reducing this common yet serious condition.

Mounjaro used for weight loss helped people with overweight or obesity lose more than 60 pounds on average when combined with diet and exercise changes.

A recent study has introduced a novel perspective, suggesting that medications commonly used to treat ED could play a role in reducing the risk of developing Alzheimer's disease.

The health study found medications commonly prescribed for erectile dysfunction are associated with significant reductions in deaths, cardiovascular disease, and dementia ...